Please login to the form below

Not currently logged in
Email:
Password:

Celltrion Healthcare

This page shows the latest Celltrion Healthcare news and features for those working in and with pharma, biotech and healthcare.

Mundipharma adds breast cancer biosimilar to its portfolio with Celltrion deal

Mundipharma adds breast cancer biosimilar to its portfolio with Celltrion deal

Mundipharma has strengthened its partnership with biopharmaceutical group Celltrion Healthcare by securing rights to its trastuzumab biosimilar. ... Commenting on the partnership, Man Hoon Kim, president and CEO of Celltrion Healthcare, said: “We are

Latest news

  • Standing out in a crowd Standing out in a crowd

    Celltrion Healthcare’s Ho-Ung Kim on pricing, market access and regulatory challenges for successfully developing biosimilars. ... PME sat down recently to discuss pricing, market access and regulatory challenges with Ho-Ung Kim, division head of

  • Mundipharma to launch first MabThera biosimilar in EU Mundipharma to launch first MabThera biosimilar in EU

    approval. Developed by South Korean biosimilar specialist Celltrion Healthcare, Truxima is set to be launched in the UK, Germany, Italy, the Netherlands, Belgium, Ireland and Luxembourg by UK-based pharma network

  • Patients 'sceptical' about biosimilars, says EULAR Patients 'sceptical' about biosimilars, says EULAR

    A cost-effective treatment option like biosimilar infliximab will help to decrease the current and extensive burden on healthcare systems across Europe," commented Celltrion chief executive Stanley Hong. ... as $50bn in savings to healthcare systems

  • First mAb biosimilars set for European approval First mAb biosimilars set for European approval

    Celltrion and Hospira's versions of J&J's blockbuster Remicade recommended by CHMP. ... infliximab) filed by Celltrion Healthcare and Hospira.

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
wethepeople

wethepeople are bringing human appeal back to brand communications. Our approach allows us to create strategies, ideas and experiences that...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics